Business Description
Epitomee Medical Ltd
ISIN : IL0011825911
Share Class Description:
XTAE:EPIT: Ordinary SharesDescription
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.9 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.76 | |||||
Interest Coverage | 897.33 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.4 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -20 | |||||
3-Year Book Growth Rate | 105.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.78 | |||||
9-Day RSI | 63.66 | |||||
14-Day RSI | 59.7 | |||||
6-1 Month Momentum % | -3.85 | |||||
12-1 Month Momentum % | -63.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 15.87 | |||||
Quick Ratio | 15.87 | |||||
Cash Ratio | 15.65 | |||||
Days Sales Outstanding | 8.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.49 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 7.3 | |||||
Net Margin % | -60.35 | |||||
FCF Margin % | -109.35 | |||||
ROE % | -18.18 | |||||
ROA % | -14.4 | |||||
ROIC % | 9.37 | |||||
ROC (Joel Greenblatt) % | -89.54 | |||||
ROCE % | -15.06 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 16.86 | |||||
PS Ratio | 2.77 | |||||
PB Ratio | 0.93 | |||||
Price-to-Tangible-Book | 0.93 | |||||
EV-to-EBIT | -0.46 | |||||
EV-to-EBITDA | -0.53 | |||||
EV-to-Revenue | 0.26 | |||||
EV-to-FCF | 0.04 | |||||
Price-to-Graham-Number | 0.83 | |||||
Price-to-Net-Current-Asset-Value | 1.16 | |||||
Price-to-Net-Cash | 1.18 | |||||
Earnings Yield (Greenblatt) % | -215.92 | |||||
FCF Yield % | -39.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Epitomee Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 36.901 | ||
EPS (TTM) (₪) | -0.749 | ||
Beta | 0 | ||
Volatility % | 109.39 | ||
14-Day RSI | 59.7 | ||
14-Day ATR (₪) | 0.224937 | ||
20-Day SMA (₪) | 3.01355 | ||
12-1 Month Momentum % | -63.42 | ||
52-Week Range (₪) | 2.494 - 19.48 | ||
Shares Outstanding (Mil) | 29.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Epitomee Medical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Epitomee Medical Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Epitomee Medical Ltd Frequently Asked Questions
What is Epitomee Medical Ltd(XTAE:EPIT)'s stock price today?
The current price of XTAE:EPIT is ₪3.44. The 52 week high of XTAE:EPIT is ₪19.48 and 52 week low is ₪2.49.
When is next earnings date of Epitomee Medical Ltd(XTAE:EPIT)?
The next earnings date of Epitomee Medical Ltd(XTAE:EPIT) is .
Does Epitomee Medical Ltd(XTAE:EPIT) pay dividends? If so, how much?
Epitomee Medical Ltd(XTAE:EPIT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |